The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction

Non ancora tradotto Non ancora tradotto
Autori
Categoria Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study is a multicenter, open-label, randomized controlled trial. It will prospectively compare outcomes between patients undergoing reverse-sequence endoscopic NSM (R-E-NSM) with direct-to-implant breast reconstruction (DIBR) with the \"HUAXI Hole 1\" versus without the \"HUAXI Hole 1\". The study aims to evaluate differences in operative efficiency, surgical safety, postoperative aesthetics, and oncological safety between the two groups.
Epistemonikos ID: b2235c14cc2dfd1f22753d28005a249d0b00127d
First added on: May 31, 2025